Ozelle Presents AI-Assisted Hematology and Cell Morphology Analysis

By LabMedica International staff writers
Posted on 16 Nov 2026

Ozelle showcases its AI-assisted hematology analyzers and diagnostic workflow solutions at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. The company highlights its O-Cyte 1 automated hematology analyzer, alongside other systems integrating cell morphology analysis, immunoassay, and clinical chemistry testing. The technologies are designed to support routine laboratory testing and decentralized diagnostic workflows.

Among the featured products is the O-Cyte 1, which combines complete blood count (CBC) testing with 7-part white blood cell differentiation and AI-assisted cell morphology analysis. The analyzer integrates high-resolution cell imaging and automated cell classification, allowing laboratory professionals to review individual cell images alongside numerical results when further evaluation is required.


Image: The O-Cyte 1 processes up to 60 tests per hour and scales to 360 with six connected analyzers while maintaining AI-assisted morphology analysis (Photo courtesy of Ozelle)

The O-Cyte 1 supports a throughput of up to 60 tests per hour as a standalone analyzer, with capacity expandable to 360 tests per hour through six connected units. This modular configuration enables laboratories to adjust testing capacity according to workload. The system is designed to accommodate different laboratory volumes while maintaining access to AI-assisted morphology analysis.

The analyzer also incorporates an integrated reagent kit and consumable-contained fluid-contact components to simplify reagent handling and routine maintenance. Built-in self-checks and replaceable modules support troubleshooting and servicing, while the modular design is intended to reduce operational complexity and facilitate technical support across laboratory environments.

Alongside the O-Cyte 1, Ozelle presents the EHBT-75 automated hematology analyzer, which combines 7-part white blood cell differentiation with cell imaging and morphology analysis. The company also features the EHBT-50, a compact multifunctional platform integrating hematology, immunoassay, and dry biochemistry testing to address diagnostic requirements in different clinical settings.

Ozelle also highlights Open Dx, its AI Workbench designed to support AI-assisted report review and diagnostic result sharing. The software complements the company's hematology analyzers by providing tools for reviewing and managing test information. Together, these technologies are intended to support laboratory workflows that combine automated testing, cell morphology assessment, and digital data management.

The exhibition reflects Ozelle's focus on integrating AI-assisted cell classification with scalable hematology testing and simplified instrument maintenance. By combining numerical blood analysis with reviewable cell images, the company aims to support laboratory professionals in evaluating hematology results while accommodating varying testing volumes and operational requirements.

Ozelle exhibits at Booth D63 in Hall 1, where visitors can explore its hematology analyzers, multifunctional diagnostic platforms, and digital workflow solutions. The company uses its participation at MEDICA 2026 to engage with laboratory professionals and distribution partners and discuss applications for its diagnostic technologies across different healthcare environments.


Latest Medica 2026 News